Skip to main content

Advertisement

SpringerLink
Log in

Distal Bile Duct Carcinoma: Prognostic Factors After Curative Surgery. A Series of 112 Cases

  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

The identification of independent prognostic indicators in distal bile duct carcinomas (DBDCs) has been limited by the small number of tumors and a lack of molecular prognostic markers. Markers assessed in combination may perform better than those considered individually. We conducted this study to identify prognostic predictors of patients with DBDC with special focus on combination of expression of p53 protein and clinicopathological predictors.

Methods

Between December 1996 and 2002, 112 consecutive patients undergoing pancreaticoduodenectomy in the Eastern Hepatobiliary Surgery Hospital for distal bile duct carcinomas were identified in a prospectively collected database. The survival of patients was comparable with respect to patient characteristics, clinicopathological factors and degree of p53 protein expression followed by a univariate and multivariate analysis.

Results

Actual 1, 3, and 5-year survival rates were 85.7, 50.9, and 25.0%, respectively. By Cox proportional hazards survival analysis, the most powerful predictors of survival rate were p53 expression [relative risk (RR) 5.2, 95% CI 4.8–5.6], pancreatic invasion (RR 5.6, 95% CI 4.3–6.9), lymph nodes metastasis (RR 3.9, 95% CI 3.3–4.5), and operative time (RR 1.8, 95% CI 1.5–2.1).

Conclusions

Overexpression of p53 in DBDC is strongly associated with significantly reduced survival, independently of clinicopathological prognostic factors. The resection margin status provides little independent prognostic information. Longer operative time may have unfavorable effect on prognosis of patients with DBDC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

FIG. 1.
FIG. 2.
FIG. 3.

Similar content being viewed by others

References

  1. Fong Y, Blumgart LH, Lin E, Fortner JG, Brennan MF. Outcome of treatment for distal bile duct cancer. Br J Surg 1996; 83:1712–15

    Article  PubMed  CAS  Google Scholar 

  2. Andersen HB, Baden H, Brahe NE, Burcharth F. Pancreaticoduodenectomy for periampullary adenocarcinoma. J Am Coll Surg 1994; 179:545–52

    PubMed  CAS  Google Scholar 

  3. Lerut JP, Gianello PR, Otte JB, Kestens PJ. Pancreaticoduodenal resection: Surgical experience and evaluation of risk factors in 103 patients. Ann Surg 1984; 199:432–7

    Article  PubMed  CAS  Google Scholar 

  4. Jones BA, Langer B, Taylor BR, Girotti M. Periampullary tumors: which ones should be resected? Am J Surg 1985; 149:46–52

    Article  PubMed  CAS  Google Scholar 

  5. Tarazi RY, Hermann RE, Vogt DP, et al. Results of surgical treatment of periampullary tumors: a thirty-five-year experience. Surgery 1986; 100:716–22

    PubMed  CAS  Google Scholar 

  6. Chan C, Herrera MF, de la Garza L, et al. Clinical behavior and prognostic factors of periampullary adenocarcinoma. Ann Surg 1995; 222:632–7

    Article  PubMed  CAS  Google Scholar 

  7. Tompkins RK, Thomas D, Wile A, Longmire WP Jr. Prognostic factors in bile duct carcinoma. Ann Surg 1981; 194:447–57

    Article  PubMed  CAS  Google Scholar 

  8. Alexander F, Rossi RL, O’Bryan M, Khettry U, Braasch JW, Watkins E Jr. Biliary carcinoma: a review of 109 cases. Am J Surg 1984; 147:503–9

    Article  PubMed  CAS  Google Scholar 

  9. Reding R, Buard JL, Lebeau G, Launois B. Surgical management of 552 carcinomas of the extrahepatic bile ducts (gallbladder and periampullary tumors excluded). Ann Surg 1991; 213:236–41

    Article  PubMed  CAS  Google Scholar 

  10. Nagorney DH, Donohue JH, Farnell MB, Schleck CD, Ilstrup DM. Outcomes after curative resections of cholangiocarcinoma. Arch Surg 1993; 128:871–9

    PubMed  CAS  Google Scholar 

  11. Rijken AM, Umezawa A, van Gulik TM, et al. Prognostic value of cell proliferation (Ki-67 antigen) and nuclear DNA content in clinically resectable, distal bile duct carcinoma. Ann Surg Oncol 1998; 5:699–705

    Article  PubMed  CAS  Google Scholar 

  12. Wade TP, Prasad CN, Virgo KS, Johnson FE. Experience with distal bile duct cancers in US Veterans Affairs hospitals: 1987–1991. J Surg Oncol 1997; 64:242–5

    Article  PubMed  CAS  Google Scholar 

  13. Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996; 224:463–73

    Article  PubMed  CAS  Google Scholar 

  14. Launois B, Terblanche J, Lakehal M, et al. Proximal bile duct cancer: high resectability rate and 5-year survival. Ann Surg 1999; 230:266–75

    Article  PubMed  CAS  Google Scholar 

  15. Blom D, Schwartz SI. Surgical treatment and outcomes in carcinoma of the extrahepatic bile ducts: the University of Rochester experience. Arch Surg 2001; 136:209–15

    Article  PubMed  CAS  Google Scholar 

  16. Reed DN Jr, Vitale GC, Martin R, et al. Bile duct carcinoma: trends in treatment in the nineties. Am Surg 2000; 66:711–5

    PubMed  Google Scholar 

  17. Li L, Lemoe KD, Cameron JL. Surgery for hilar cholangiocarcinoma: the Johns Hopkins approach. J Hepatobiliary Pancreat Surg 2000; 7:115–121

    Article  Google Scholar 

  18. Todoroki T, Koike N, Morishita Y, et al. Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater. Ann Surg Oncol 2003; 10:1176–83

    Article  PubMed  Google Scholar 

  19. Yoshida T, Matsumoto T, Sasaki A, Morii Y, Aramaki M, Kitano S. Prognostic factors after pancreatoduodenectomy with extended lymphadenectomy for distal bile duct cancer. Arch Surg 2002; 137:69–73

    Article  PubMed  Google Scholar 

  20. Bortolasi L, Burgart LJ, Tsiotos GG, Luque-De Leon E, Sarr MG. Adenocarcinoma of the distal bile duct. A clinicopathologic outcome analysis after curative resection. Dig Surg 2000; 17:36–41

    Article  PubMed  CAS  Google Scholar 

  21. He P, Shi JS, Chen WK, Wang ZR, Ren H, Li H. Multivariate statistical analysis of clinicopathologic factors influencing survival of patients with bile duct carcinoma. World J Gastroenterol 2002; 8:943–6

    PubMed  Google Scholar 

  22. Yeo CJ, Sohn TA, Cameron JL, Hruban RH, Lillemoe KD, Pitt HA. Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg 1998; 227:821–31

    Article  PubMed  CAS  Google Scholar 

  23. Brown JM, Wouters BG. Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res 1999; 59:1391–9

    PubMed  CAS  Google Scholar 

  24. Rich T, Allen RL, Wyllie AH. Defying death after DNA damage. Nature 2000; 407:777–83

    Article  PubMed  CAS  Google Scholar 

  25. Kinzler KW, Vogelstein B. Cancer therapy meets p53. N Engl J Med 1994;331:49–50

    Article  PubMed  CAS  Google Scholar 

  26. Lowe S, Bodis S, McClatchey A, et al. p53 Status and the efficacy of cancer therapy in vivo. Science 1994; 266:807–10

    Article  PubMed  CAS  Google Scholar 

  27. Thompson AM, Anderson TJ, Condie A, et al. p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters. Int J Cancer 1992; 50:528–32

    Article  PubMed  CAS  Google Scholar 

  28. Quinlan DC, Davidson AG, Summers CL, Warden HE, Doshi HM. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res 1992; 52:4828–31

    PubMed  CAS  Google Scholar 

  29. Hamelin R, Laurent-Puig P, Olschwang S, et al. Association of p53 mutations with short survival in colorectal cancer. Gastroenterology 1994; 106:42–8

    PubMed  CAS  Google Scholar 

  30. Martin HM, Filipe MI, Morris RW, Lane DP, Silvestre F. p53 expression and prognosis in gastric carcinoma. Int J Cancer 1992; 50:859–62

    Article  PubMed  CAS  Google Scholar 

  31. Sobin LH, Wittekind C. TNM classification of malignant tumors, 5th edn. New York: Wiley, 1997

    Google Scholar 

  32. Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005; 138:8–13

    Article  PubMed  Google Scholar 

  33. Lane DP. Cancer: p53, guardian of the genome. Nature 1992; 358:15–6

    Article  PubMed  CAS  Google Scholar 

  34. Rijken AM, Offerhaus GJ, Polak MM, Gouma DJ, van Gulik TM. p53 expression as a prognostic determinant in resected distal bile duct carcinoma. Eur J Surg Oncol 1999; 25:297–301

    Article  PubMed  CAS  Google Scholar 

  35. Ajiki T, Kamigaki T, Hasegawa Y, et al. Proliferating cell nuclear antigen, p53, and c-erbB-2 expression in relation to clinicopathological variables and prognosis in cancer of the ampulla of Vater. Hepatogastroenterology 2001; 48:1266–70

    PubMed  CAS  Google Scholar 

  36. Klempnauer J, Ridder GJ, von Wasielewski R, Werner M, Weimann A, Pichlmayr R. Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol 1997; 15:947–54

    PubMed  CAS  Google Scholar 

  37. Klempnauer J, Ridder GJ, Werner M, Weimann A, Pichlmayr R. What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer 1997; 79:26–34

    Article  PubMed  CAS  Google Scholar 

  38. Pichlmayr R, Weimann A, Klempnauer J, Oldhafer KJ, Maschek H, Tusch G, Ringe B. Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg 1996; 224:628–38

    Article  PubMed  CAS  Google Scholar 

  39. Fortner JG, Vitelli CE, Maclean BJ. Proximal extrahepatic bile duct tumors. Analysis of a series of 52 consecutive patients treated over a period of 13 years. Arch Surg 1989; 124:1275–9

    PubMed  CAS  Google Scholar 

  40. Sasaki R, Takahashi M, Funato O, et al. Prognostic significance of lymph node involvement in middle and distal bile duct cancer. Surgery 2001; 129:677–83

    Article  PubMed  CAS  Google Scholar 

  41. Kayahara M, Nagakawa T, Ohta T, Kitagawa H, Tajima H, Miwa K. Role of nodal involvement and the periductal soft-tissue margin in middle and distal bile duct cancer. Ann Surg 1999; 229:76–83

    Article  PubMed  CAS  Google Scholar 

  42. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 2002; 236:355–68

    Article  PubMed  Google Scholar 

  43. Kim S, Kim SW, Bang YJ, Heo DS, Ha SW. Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer. Int J Radiat Oncol Biol Phys 2002; 54:414–9

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

The authors thank Hongzhi Li and Lichen Sun for their invaluable help with the referring of medical records. We also gratefully acknowledge the excellent assistance of Jian Lu for help with the statistical works.

Author information

Authors and Affiliations

  1. Department of Biliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Changhai Road 225, Shanghai, 200438, China

    Qingbao Cheng, Xiangji Luo, Baihe Zhang, Xiaoqing Jiang, Bin Yi & Mengchao Wu

Authors
  1. Qingbao Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiangji Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Baihe Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiaoqing Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bin Yi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mengchao Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Baihe Zhang.

Additional information

Qingbao Cheng and Xiangji Luo contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cheng, Q., Luo, X., Zhang, B. et al. Distal Bile Duct Carcinoma: Prognostic Factors After Curative Surgery. A Series of 112 Cases. Ann Surg Oncol 14, 1212–1219 (2007). https://doi.org/10.1245/s10434-006-9260-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-006-9260-0

Keywords

Search

Navigation